About PTG Capital
Next-gen Buyout Firm Focused on Acquiring and Scaling MNC Divestitures into Cross-regional Platforms
PTG Capital is a next-generation PE firm specializing in acquiring and growing MNC divestitures in pharma and medtech across Asia-Pacific region, leveraging proprietary deal sourcing, deep domain expertise, activist operator-investor approach and visible exit strategy to unlock hidden value and drive scalable growth
PTG Persona
First-ever Pan-APAC Divestiture Fund with Active Alpha Value Creation
Pan-APAC Buyout Fund of Disruptive Investment Paradigm (PTG Fund I)
”Transforming Divestitures into Market Leaders, A Clear Path to Build Healthcare MNC”
.
01
Pan-APAC Focus
Only fund with a devoted strategy to unlock carveout
opportunities across Pan-APAC pharma and medtech market
02
Carve-Out Specialist
Build on deep operational, regulatory, and transactional expertise across regional, business,
and asset-level
03
Proprietary Access
Off-market visibility and deal origination via deep relationships with global and regional leaders at
MNCs, built on our history of successful partnerships andtransactions
04
Active Alpha Engine
Beyond capital, hands-on value creation via TOT
(total operation transformation), commercial scaling, territorial expansion and add-on M&A/licensing
05
Exit-Driven Discipline
Engagement with source of liquidity at project onset and throughout the project life cycle; Strong bias toward structured exits via trade sales, IPOs, or strategic M&A